Filter
216
Filtered Results: 216
Text search:
Ortesista
Featured
Recommendations
20
New Publications
30
Language
Document type
Studies & Reports
68
Guidelines
63
No document type
35
Manuals
19
Strategic & Response Plan
12
Fact sheets
11
Situation Updates
4
Training Material
3
Infographics
1
Countries / Regions
India
10
Global
7
Ethiopia
7
Kenya
6
Africa
6
Latin America and the Carribbean
6
Western and Central Europe
5
South Africa
5
Colombia
3
Zambia
3
Thailand
2
Syria
2
Nigeria
2
Tanzania
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Indonesia
2
El Salvador
1
Sierra Leone
1
China
1
Philippines
1
USA
1
Asia
1
Jordan
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Denmark
1
Spain
1
East and Southern Africa
1
Bolivia
1
Argentina
1
Bangladesh
1
Sri Lanka
1
Sudan
1
Mali
1
Iraq
1
Somalia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
46
Clinical Guidelines
24
Public Health
11
Women & Child Health
4
Key Resources
2
Pharmacy & Technologies
1
Toolboxes
AMR
103
TB
18
Disability
14
Planetary Health
11
NTDs
10
HIV
9
COVID-19
7
Pharmacy
4
Conflict
4
NCDs
3
Natural Hazards
2
Caregiver
2
Zika
2
Global Health Education
2
Mental Health
1
Refugee
1
Cholera
1
Ebola & Marburg
1
Malaria
1
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ...
Today’s children, and their children, are the ones who will live with the consequences of climate change.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
Final Survey Report
The global tripartite self-assessment survey of country progress in addressing antimicrobial resistance (AMR) is a component of a broader approach for monitoring and evaluation of the global action plan on AMR. This report analyses the results of the second tripartite self-assessment survey
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
The figures and findings reflected in the 2020 PMR represent the independent analysis of the United Nations (UN) and its humanitarian partners based on information available to them. Many of the figures provided throughout the document are estimates based on sometimes incomplete and partial data set...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
Version corregida. En la actualidad, las guías basadas en la evidencia constituyen una de las herramientas más útiles para mejorar la salud pública y la práctica clínica. Su finalidad es formular intervenciones con sólidas pruebas de eficacia, evitar riesgos innecesarios, utilizar los recurso...
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
The COVID-19 pandemic has provided a dramatic illustration of the extent to which the health of people, animals and the environment is interdependent, which is why “One Health” is now high on the political agenda. This document provides an overview of KfW Development Bank’s approach to promoti...
